Langkau ke kandungan utama
Penerbitan

Accessibility to plasma-derived medicinal products in Malaysia: The challenges faced by patients with inborn errors of immunity

Oleh #!30Isn, 01 Apr 2024 01:19:57 +0000p5730#30Isn, 01 Apr 2024 01:19:57 +0000p-1+00:003030+00:00x30 01am30am-30Isn, 01 Apr 2024 01:19:57 +0000p1+00:003030+00:00x302024Isn, 01 Apr 2024 01:19:57 +0000191194amIsnin=331#!30Isn, 01 Apr 2024 01:19:57 +0000p+00:004#April 1st, 2024#!30Isn, 01 Apr 2024 01:19:57 +0000p5730#/30Isn, 01 Apr 2024 01:19:57 +0000p-1+00:003030+00:00x30#!30Isn, 01 Apr 2024 01:19:57 +0000p+00:004#Tiada komen1 min baca

Catatan Serupa

Penerbitan

E-Majalah ‘MyHealth for Life’ Edisi Jun 2024

Pada 11 Jun 2024, MYPOPI telah menjalinkan usahasama bersama @kementeriankesihatanmalaysia bagi menerbitkan e-Majalah MyHealth for Life Edisi…
Nafis
NafisJun 25, 2024
Penerbitan

Research Collaboration: Knowledge, awareness, and perception on genetic testing for primary immunodeficiency disease among parents in Malaysia: a qualitative study

26 January 2024 -  A new publication of a research collaboration between MYPOPI and UKM…
Admin MyPOPI
Admin MyPOPIJanuari 26, 2024
Penerbitan

Immunoglobulin Accessibility For Patients With Primary Immunodeficiencies: Getting The Priorities Right— Dr Lokman Mohd Noh

🔍 "Ever wondered why access to Immunoglobulin Therapy is crucial for Primary Antibody Deficiency patients❓❔…
Nafis
NafisJanuari 23, 2024
Langkau ke kandungan